Fig. 1From: Targeted metabolomics reveals plasma short-chain fatty acids are associated with metabolic dysfunction-associated steatotic liver diseasePercentage difference in SCFA concentrations between patients with MASLD and healthy controls expressed as sympercents (s%). Data were analysed by multivariable linear regression models adjusted for age and sexBack to article page